Aileron Therapeutics, Inc.·4

Dec 4, 4:05 PM ET

WINDSOR JAMES BRIAN 4

4 · Aileron Therapeutics, Inc. · Filed Dec 4, 2024

Insider Transaction Report

Form 4
Period: 2024-12-02
WINDSOR JAMES BRIAN
President and COO
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-02+517,500517,500 total
    Exercise: $2.85Exp: 2034-12-01Common Stock (517,500 underlying)
Footnotes (1)
  • [F1]This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest as of 25% of the shares on December 2, 2025 and thereafter in equal monthly installments through December 2, 2028.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4